Assenagon Asset Management S.A. Burning Rock Biotech LTD Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$2.16 - $3.47 $170,810 - $274,404	-79,079 Reduced 22.38%	274,250 $770,000
Q4 2022 Jan 12, 2023	SELL	$1.73 - $2.95 $2,133 - $3,637	-1,233 Reduced 0.35%	353,329 $795,000
Q3 2022 Oct 27, 2022	SELL	$2.39 - $3.96 $196,460 - $325,515	-82,201 Reduced 18.82%	354,562 $847,000
Q2 2022 Jul 27, 2022	BUY	$1.75 - $10.44 $764,335 - $4.56 Million	436,763 New	436,763 $1.27 Million
Q4 2021 Feb 01, 2022	SELL	$9.43 - $17.14 $576,785 - $1.05 Million	-61,165 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$17.37 - $27.92 $1.06 Million - $1.71 Million	61,165 New	61,165 $1.09 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.